RecruitingOBSERVATIONAL

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Doctors are studying patients admitted to intensive care because of a serious heart condition called cardiogenic shock. This condition happens when your heart suddenly can't pump enough blood to meet your body's needs, and it's a common reason for intensive care admission. Sadly, about half of people with cardiogenic shock don't survive. This study aims to understand how a patient's blood flow and heart function change during their hospital stay, and whether these changes are connected to their survival. Researchers will look at existing information from patients' medical records, including details about their health, blood tests, and how their heart and blood vessels are working. The goal is to use this information to improve our understanding and care for people experiencing cardiogenic shock in the future.

At a glance

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire, Amiens

Enrolment target

500

Start

24 Jan 2023

Estimated completion

01 Jan 2029

Cardiogenic Shock

What is this study about?

This study is looking at people who are admitted to intensive care because of a serious condition called cardiogenic shock. This means your heart can't pump enough blood to your body, which is a life-threatening emergency. Unfortunately, cardiogenic shock is quite common in intensive care and about half of those affected don't survive. Doctors are always looking for better ways to understand and treat this condition.

Over the years, doctors have found new ways to support the heart during cardiogenic shock, including special equipment that helps the heart pump. They also use a system called the 'vaso-inotropic score' to track how seriously ill a patient is and how their medication is working. This study is designed to use all this new information and technology to get a clearer picture of how cardiogenic shock affects patients in intensive care.

The main aim of this study is to see if there's a link between how a patient's heart and blood circulation change during their hospital stay and whether they survive. By carefully looking at information already gathered as part of routine care – things like blood test results, heart function measurements, and other health details – the researchers hope to learn more about what helps or hinders recovery from cardiogenic shock. This knowledge could help doctors make better decisions and improve care for future patients.

Key takeaways

The study looks at medical records of patients with cardiogenic shock in intensive care.
It aims to understand how heart function changes are linked to survival.
No new treatments, tests, or procedures for patients in the study.
Information gathered could help improve care for future patients.
Your personal details will be kept private and anonymous.
Participation involves no extra effort or changes to your medical care.

Who may be eligible?

To be part of this study, you need to be an adult, aged 18 or over. You must have been admitted to the intensive care unit specifically because you have cardiogenic shock. This means your heart isn't pumping enough blood to your body, and your doctors have diagnosed it using specific medical guidelines for this condition.

However, some people with cardiogenic shock won't be included. This study is not for those whose cardiogenic shock is caused by a very bad infection (called septic shock) or by severe blood loss (called hemorrhagic shock). The researchers are focusing on cardiogenic shock that has other causes.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Were you admitted to intensive care because of cardiogenic shock?
Was your cardiogenic shock NOT caused by a severe infection or major blood loss?

Answer every question to see your result.

What does participation involve?

If you are eligible for this study, you wouldn't need to do anything extra. This isn't a study where you would take new medication or have additional tests. The researchers will simply be looking at information that's already collected as part of your standard medical care during your stay in the intensive care unit for cardiogenic shock. This includes details from your hospital notes, blood test results, and measurements of your heart and blood circulation. There will be no extra visits, assessments, or follow-up appointments related to this study. The study looks at your records during your time in the intensive care unit, so there's no ongoing commitment after your hospital stay.

Potential risks and benefits

Since this study only involves looking at information from your medical records that have already been collected as part of your usual care, there are no direct risks to you from taking part. You will not have any extra tests, treatments, or procedures. The potential benefit is to future patients; the information gathered could help doctors better understand cardiogenic shock and improve treatments, potentially saving lives in the future. You always have the right to withdraw your consent for your anonymised data to be used in the study at any time, without it affecting your medical care.

Locations (1)

CHU Amiens Picardie
Verified postcode
Amiens, France· Recruiting

Common questions

What is cardiogenic shock?

It's a serious condition where your heart suddenly can't pump enough blood to meet your body's needs, often leading to admission to intensive care.

Will I have to take any new medicines or have extra tests?

No, this study only uses information already collected from your standard medical care in the hospital; you won't have any extra treatments or tests.

Who is running this study?

This study is being conducted by doctors and researchers in an intensive care unit, to help them learn more about cardiogenic shock.

Will my personal details be shared?

No, your information will be kept private and anonymised, meaning your name or anything that could identify you won't be used in the study results.

Why is this study important?

By understanding more about how cardiogenic shock develops and affects patients, doctors hope to improve care and survival rates for people in the future.

How to find out more

Christophe Beyls, MD

beyls.christophe@chu-amiens.fr 03 22 08 78 66 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.